TP 595 Pre-clinical estimation of cetuximab using nano-surface and molecular orientation limited (nSMOL) proteolysis and LC-MS/MS Deepti Bhandarkar, Rashi Kochhar, Shailendra Rane, Shailesh Damale, Purushottam Sutar, Anant Lohar, Ashutosh Shelar, Navin Devadiga, Bhaumik Trivedi, Ajit Datar, Pratap Rasam and Jitendra…
Key words
nsmol, cetuximab, proteolysis, wistar, fab, cup, rat, specificity, antibody, region, peptides, selective, gpsvfplapssk, filter, plasma
